Science
Mechanism of Action
Operating primarily as a selective COX-2 inhibitor, N-Caffeoyl Serotonin is posited to reduce inflammatory pathways within the skin. Its structural framework, particularly the caffeic acid moiety, is associated with potent antioxidant activity, including the reduction of intracellular reactive oxygen species (ROS). Furthermore, insights from analogous serotonin derivatives found in safflower seeds suggest its capacity to inhibit tyrosinase activity and downregulate melanin-producing enzymes (TYR, TRP-1, TRP-2) by suppressing MITF phosphorylation, thereby addressing hyperpigmentation. It may also support fibroblast growth and collagen synthesis.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 N-Caffeoyl serotonin exhibited excellent selective inhibition of COX-2 at a concentration of 42.5 µM.
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
N-Caffeoyl Serotonin is registered in the FDA Global Substance Registration System (UNII 574297D1EQ, CAS 928765-97-3); however, no specific safety status or assessment for cosmetic use, such as GRAS or CIR review, has been established.
Your Skin
Skin Compatibility
Our Assessment
Verdict
N-Caffeoyl Serotonin presents a compelling theoretical profile for anti-inflammatory, antioxidant, and brightening benefits, but its application requires further robust clinical investigation and comprehensive safety assessment for cosmetic use.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources